开云app官网登录入口网页版-官方正版

#阿可拉定#

6篇内容 | 1132人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1743402, encodeId=abc91e434024b, content=<a href='/topic/show?id=ed9d9e733e1' target=_blank style='color:#2F92EE;'>#阿可拉定#</a>, objectTitle=CSCO 2021：秦叔逵教授报告阿可拉定一线治疗基线较重预后较差晚期肝细胞癌结果, objectType=article, longId=217674, objectId=aa6321e674ae, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=aa6321e674ae, replyNumber=0, likeNumber=86, createdTime=2022-02-07, rootId=0, userName=Luyuxie_21, userId=d58035126206, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=aa6321e674ae, moduleTitle=CSCO 2021：秦叔逵教授报告阿可拉定一线治疗基线较重预后较差晚期肝细胞癌结果, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=aa6321e674ae)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1743403, encodeId=4c8e1e434035a, content=<a href='/topic/show?id=ed9d9e733e1' target=_blank style='color:#2F92EE;'>#阿可拉定#</a>, objectTitle=NMPA批准中药一类新药淫羊藿素（阿可拉定）软胶囊用于肝癌治疗，华东医药获推广权, objectType=article, longId=294113, objectId=9c492941132f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9c492941132f, replyNumber=0, likeNumber=84, createdTime=2022-01-28, rootId=0, userName=Luyuxie_21, userId=d58035126206, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9c492941132f, moduleTitle=NMPA批准中药一类新药淫羊藿素（阿可拉定）软胶囊用于肝癌治疗，华东医药获推广权, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=9c492941132f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1743401, encodeId=a22f1e4340108, content=<a href='/topic/show?id=ed9d9e733e1' target=_blank style='color:#2F92EE;'>#阿可拉定#</a>, objectTitle=Carcinogenesis：阿可拉定通过IL-6/Stat3和极光激酶A信号通路抑制TRAMP小鼠的前列腺癌, objectType=article, longId=67133, objectId=ed8e6e133fa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ed8e6e133fa, replyNumber=0, likeNumber=97, createdTime=2016-08-30, rootId=0, userName=Luyuxie_21, userId=d58035126206, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ed8e6e133fa, moduleTitle=Carcinogenesis：阿可拉定通过IL-6/Stat3和极光激酶A信号通路抑制TRAMP小鼠的前列腺癌, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=ed8e6e133fa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1743398, encodeId=ef291e4339819, content=<a href='/topic/show?id=ed9d9e733e1' target=_blank style='color:#2F92EE;'>#阿可拉定#</a>, objectTitle=Oncotarget：阿可拉定可能对难治性多发性骨髓瘤有效, objectType=article, longId=48532, objectId=ec8e485320f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ec8e485320f, replyNumber=0, likeNumber=68, createdTime=2015-09-04, rootId=0, userName=Luyuxie_21, userId=d58035126206, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ec8e485320f, moduleTitle=Oncotarget：阿可拉定可能对难治性多发性骨髓瘤有效, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=ec8e485320f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1743399, encodeId=c8c61e43399dd, content=<a href='/topic/show?id=ed9d9e733e1' target=_blank style='color:#2F92EE;'>#阿可拉定#</a>, objectTitle=Carcinogenesis：中药阿可拉定或可成为耐药性前列腺癌新疗法, objectType=article, longId=49934, objectId=7ee24993409, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7ee24993409, replyNumber=0, likeNumber=76, createdTime=2016-02-23, rootId=0, userName=Luyuxie_21, userId=d58035126206, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7ee24993409, moduleTitle=Carcinogenesis：中药阿可拉定或可成为耐药性前列腺癌新疗法, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=7ee24993409)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1743400, encodeId=96e71e43400f3, content=<a href='/topic/show?id=ed9d9e733e1' target=_blank style='color:#2F92EE;'>#阿可拉定#</a>, objectTitle=Carcinogenesis：新加坡科研人员揭示中药阿可拉定或可成为耐药性前列腺癌新疗法, objectType=article, longId=50024, objectId=409b50024fb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=409b50024fb, replyNumber=0, likeNumber=103, createdTime=2015-06-25, rootId=0, userName=Luyuxie_21, userId=d58035126206, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=409b50024fb, moduleTitle=Carcinogenesis：新加坡科研人员揭示中药阿可拉定或可成为耐药性前列腺癌新疗法, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=409b50024fb)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 风湿免疫小助手

阿可拉定

2020-05-29

Luyuxie_21 (审核中...)

前往app查看评论内容

#阿可拉定#

CSCO 2021：秦叔逵教授报告阿可拉定一线治疗基线较重预后较差晚期肝细胞癌结果

2022-02-07

Luyuxie_21 (审核中...)

前往app查看评论内容

#阿可拉定#

NMPA批准中药一类新药淫羊藿素（阿可拉定）软胶囊用于肝癌治疗，华东医药获推广权

2022-01-28

Luyuxie_21 (审核中...)

前往app查看评论内容

#阿可拉定#

Carcinogenesis：阿可拉定通过IL-6/Stat3和极光激酶A信号通路抑制TRAMP小鼠的前列腺癌

2016-08-30

Luyuxie_21 (审核中...)

前往app查看评论内容

#阿可拉定#

Oncotarget：阿可拉定可能对难治性多发性骨髓瘤有效

2015-09-04

Luyuxie_21 (审核中...)

前往app查看评论内容

#阿可拉定#

Carcinogenesis：中药阿可拉定或可成为耐药性前列腺癌新疗法

2016-02-23

Luyuxie_21 (审核中...)

前往app查看评论内容

#阿可拉定#

Carcinogenesis：新加坡科研人员揭示中药阿可拉定或可成为耐药性前列腺癌新疗法

2015-06-25

科室
- - 订阅+
  - 更多科室
工具
服务